Back

Levosimendan, milrinone and dobutamine in acute experimental pulmonary embolism.

14 March 2021 (05:50 - 06:40)
Organised by:
Congress Presentation Part of: Young Investigators Award session Pharmacotherapy ACVC Premium Access ACVC 2021

About the speaker

Photo
Doctor Mads Dam Lyhne

Aarhus University Hospital, Aarhus (Denmark)

4 More presentations in this session

Presentation thumbnail
Long-term 5-year outcome of the randomized IMPRESS in severe shock trial: percutaneous mechanical circulatory support versus intra-aortic balloon pump in severe cardiogenic shock.
Ms M. Karami (Amsterdam, NL)
Abstract Video
Presentation thumbnail
Systolic blood pressure and outcome in patients admitted with acute heart failure: a pooled analysis from 4 randomized clinical trials.
Doctor J. Grand (Copenhagen, DK)
Abstract
Presentation thumbnail
Inflammation and neurohormonal activation is increased at hospital admission in patients with ST-elevation myocardial infarction with diabetes compared to non-diabetic patients.
Unknown J. Kunkel (Copenhagen, DK)
Abstract Video
Presentation thumbnail
Time to awakening tendency and withdrawal of life supporting treatment (WLST) in patients treated with therapeutic hypothermia after cardiac arrest.
Miss M. Rivadeneira Ruiz (Madrid, ES)
Abstract Video

Access the full session

Session thumbnail
Young Investigators Award session
Video

The Event

Event poster

ACVC 2021

14 March 2021 05:50 CET
You may be interested in
thumbnail
Congress Presentation
Inodilators in acute heart failure: what about the right ventricle?
13 December 2024
thumbnail
Webinar
Percutaneous therapies for acute pulmonary embolism: state-of-the-art
30 May 2023
thumbnail
Congress Presentation
Syncope in relation to pulmonary arterial obstructive burden, hemodynamic status and short- and long-term outcome in patients with acute pulmonary embolism
28 August 2020
thumbnail
Congress Presentation
The effect of Levosimendan in weaning from veno-arterial extracorporeal membrane oxygenation in patients with postcardiotomy shock
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources